1. mir-330-5p from mesenchymal stem cell-derived exosomes targets SETD7 to reduce inflammation in rats with cerebral ischemia-reperfusion injury.
- Author
-
Liu W, Shen Y, Pan R, and Qi X
- Subjects
- Animals, Rats, Male, Rats, Sprague-Dawley, Disease Models, Animal, Infarction, Middle Cerebral Artery therapy, Infarction, Middle Cerebral Artery metabolism, Brain Ischemia metabolism, Brain Ischemia genetics, Brain Ischemia therapy, MicroRNAs genetics, MicroRNAs metabolism, Reperfusion Injury metabolism, Reperfusion Injury therapy, Reperfusion Injury genetics, Reperfusion Injury pathology, Mesenchymal Stem Cells metabolism, Exosomes metabolism, Exosomes transplantation, Inflammation pathology, Inflammation metabolism, Inflammation genetics, Histone-Lysine N-Methyltransferase metabolism, Histone-Lysine N-Methyltransferase genetics
- Abstract
This study was to investigate the role of microRNA (miR)-330-5p derived from mesenchymal stem cells-secreted exosomes (MSCs-Exo) in cerebral ischemia-reperfusion injury (CI/RI) through targeting lysine N-methyltransferase SET domain containing 7 (SETD7). MSCs-Exo were separated and identified. MSCs-Exo were used to treat the middle cerebral artery occlusion (MCAO) rat model. By using the nerve injury score, Nissl, hematoxylin and eosin, and terminal deoxynucleotidyl transferase dUTP nick-end labeling staining, the neural function, pathological alterations, and neuronal death in MCAO rats were examined. Using an enzyme-linked immunosorbent test, tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 in brain homogenate were tested. Rat brain expression levels of SETD7 and miR-330-5p were examined. Subsequently, the effects of MSCs-Exo, miR-330-5p, and SETD7 on neurological function and pathological alterations were assessed using gain and loss function tests. miR-330-5p expression was decreased and SETD7 expression was increased in the brain tissue of MCAO rats. Both MSCs-Exo and MSCs-Exo-derived miR-330-5p reduced inflammation in MCAO rats. miR-330-5p targeted SETD7, and SETD7 upregulation blocked the therapeutic effect of MSCs-Exo-derived miR-330-5p on MCAO rats. MSCs-Exo-derived miR-330-5p targets SETD7 to reduce inflammation in MCAO rats, providing a new therapeutic target for CI/RI therapy., Competing Interests: Declarations. Ethics approval: The present study was approved by the Sixth Medical Centre of PLA General Hospital Animal Experimental Ethics Committee (approval number: 202005HB62). And all procedures complied with the National Institutes of Health Guide for the Use of Laboratory Animals. Competing interests: The authors declare no competing interests., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)
- Published
- 2024
- Full Text
- View/download PDF